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Object. The authors report their experience with pituitary apoplexy and evaluate the clinical significance of sphenoid 
sinus mucosal thickening found on magnetic resonance (MR) imaging.
Methods. The cases of 28 patients (19 males and nine females) with pituitary apoplexy were reviewed retrospectively. 
The mean age of the patients was 50 years (range 16-83 years), and the mean follow-up duration was 32 months (range 
1-104 months). Admission MR imaging demonstrated hemorrhage or infarction in a pituitary tumor in each patient, A clin­
ical grading scale for apoplexy was devised as follows: Grade I, presence of acute headache and/or endocrine abnormali­
ty (12 patients); Grade II, presence of the foregoing symptoms as well as cranial nerve deficit (visual and/or oculomotor; 
15 patients); and Grade III, presence of all of these symptoms and a decreased level of consciousness (one patient).
Twenty-five patients (89%) underwent early transsphenoidal resection within 9 days (80% within 72 hours) of diag­
nosis. Headaches and oculomotor paresis resolved completely in 100%, visual function resolved completely in 44% and 
partially in 56%, and hypopituitarism was reversed in 25%. Twelve patients (43%) required long-term hormone replace­
ment therapy. Two of the three patients who were treated conservatively had prolactin-secreting adenomas, which were 
treated with dopamine agonist therapy. Thickening of sphenoid sinus mucosa was present in 22 patients (79%). Fifty per­
cent of patients in Grade I and 100% of those in Grades II and III, including all those with persistent hypopituitarism and 
residual visual deficits, had thickened sphenoid sinus mucosa on MR imaging. Patients with thickened sphenoid sinus mu­
cosa had larger tumors that compressed the optic chiasm or cavernous sinus, and these individuals also had a higher rate 
of cranial nerve deficits at presentation than those without mucosal thickening (73% compared with 0%). Patients with 
thickened mucosa had a higher rate of hypopituitarism and subsequent long-term hormone replacement therapy than those 
without thickened mucosa (55% compared with 17%).
Conclusions. Thickened sphenoid sinus mucosa may correlate with higher grades of pituitary apoplexy and worse neu­
rological and endocrinological outcomes.
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t ' v  ituitary apoplexy is  a clin ical syndrom e character­
ized  by  an abrupt onset o f  signs and sym ptom s as­
A  sociated w ith hem orrhage or infarction into a pre­
existing pituitary adenom a.9-17-18-2731 In m ost instances, the 
syndrom e occurs in  patients w ith no history o f  a pituitary tu­
m or and m ay represent the first definite indication that one  
is  present. TTie lesion  sw ells  and expands, leading to com ­
pression o f  local suprasellar and parasellar structures. The 
patient typically presents w ith abrupt onset o f  a severe head­
ache often associated w ith nausea, vom iting, and m enin- 
gism . This can be accom panied by deterioration o f  visual 
acuity and visual fields, ophthalm oplegia, a decreased level 
o f  consciousness, and/or hypopituitarism .9-29 W hen severe  
pituitary apoplexy is  m isdiagnosed and left untreated, the 
neurological sequelae can result in permanent blindness and 
com a. A lthough conservative m anagem ent in select patients 
has been  advocated by som e, corticosteroid administration 
and urgent transsphenoidal decom pression remain the m ain­
stay o f  treatment.4-11-17-21-29
Abbreviations used in this paper: CT = computerized tomogra­
phy; MR = magnetic resonance.
Hem orrhage into a pituitary adenom a w as first described  
in 1898 by  a neurologist, Pearce Bailey,3 in a 50-year-old  
man w ith acrom egaly w ho presented w ith a sudden onset 
o f  headache, nausea, vom iting, fever, oculom otor palsies, 
and visual loss. A utopsy findings revealed hem orrhage in 
the intrasellar adenom a and endarteritis o f  the adenohypo­
physial vasculature. A  sim ilar case w as reported by  B leib- 
treu5 in 1905. This clin ical entity remained obscure until 
1950, w hen B rougham  and cow orkers8 described a c iin i­
copathoiogicai syndrom e in  five  patients postmortem. The 
syndrom e w as characterized by an abrupt onset o f  head­
ache, ophthalm oplegia, blindness, stupor, or com a, and 
these authors named it pituitary apoplexy.
S ince then, num erous case reports and only a few  series 
o f  patients w ith pituitary apoplexy have been  reported in the 
literature.4-u-26-29-32 The patients in the majority o f  these clin ­
ical series received  this diagnosis before the M R  im aging  
era. Arita, et al.,2 recently described thickening o f  sphenoid  
sinus m ucosa as a radiological finding during the acute 
stage o f  pituitary apoplexy (within 7  days after the onset o f  
apoplectic sym ptom s) but did not correlate it w ith the se ­
verity or clin ical outcom e o f  this disorder. In this study, w e  
review  our experience w ith 28 patients w ho presented with
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pituitary apoplexy in  the M R  im aging era. A  clin ical grad­
ing scale that w e  have developed to facilitate classification  
o f  pituitary apoplexy is described. W e also investigated and 
report on the clin ical significance o f  thickened sphenoid  
sinus m ucosa found on M R  im aging.
Clinical Material and Methods
A  retrospective review  w as perform ed in patients in  
w h om  pituitary apoplexy w as diagnosed at the U niversity  
o f  Utah School o f  M edicine betw een 1996 and 2005 . Chart 
rev iew s w ere perform ed in  accordance w ith the Health In­
surance Portability and A ccountability A ct regulations and 
university guidelines. The diagnosis w as m ade based on  
clin ical presentation and neuroim aging findings. O nly pa­
tients w h o  exhibited abrupt onset o f  sym ptom s o f  headache, 
endocrine or cranial nerve deficits, or altered leve l o f  con ­
sciousness w ere included in the study. Patients w ith asym p­
tom atic (silent) hem orrhages did not m eet the criteria o f  
clin ical pituitary apoplexy and w ere therefore excluded. 
T hose w h o presented w ith sym ptom s from  Rathke cleft 
cysts, lym phocytic hypophysitis, and nonadenom atous le ­
sions w ere also excluded. Patients in w h om  diagnostic M R  
im aging w as performed m ore than 7 days after the onset 
o f  apoplectic sym ptom s w ere also excluded. O nly patients 
w ho had suffered apoplexy from  pituitary adenom as and in  
w h om  M R  im ages w ere obtained w ithin 7 days after the on ­
set o f  apoplectic sym ptom s w ere included.
P atien t P opulation
T w enty-eight patients w ith  pituitary apoplexy w ere iden­
tified. T he m ale/fem ale ratio w as approxim ately 2:1 (19  
m ales and 9 fem ales). T he m ean age w as 50  years (range 
16 -8 3  years). T he m ean fo llow -up  duration w as 32  months 
(range 1 -1 0 4  m onths). T w enty-five patients had nonfunc­
tioning adenom as, tw o had prolactin-secreting adenom as, 
and one had a growth horm one-secreting adenom a. The 
overall incidence o f  pituitary apoplexy am ong patients w ith  
surgically treated pituitary adenom as during the study peri­
od w as 10% (25 o f  25 2  cases).
C lin ical P resen tation
Each patient w as evaluated for clinical presentation, neu­
roim aging findings, possib le precipitating factors, histo- 
pathological features, tumor type, visual and cranial nerve 
outcom e, and endocrinological outcom e. A ll patients under­
w ent an endocrinological workup at the tim e o f  adm ission  
and w ere started on a regim en o f  intravenous corticosteroid  
drugs. Patients w ith  prolactin-secreting adenom as w ere con­
sidered for dopam ine agonist therapy.
Each M R  im age w as evaluated for the presence o f  thick­
ening and enhancem ent o f  sphenoid sinus m ucosa. The 
thickness o f  the sphenoid sinus m ucosa adjacent to the se l­
lar floor w as measured on T r  or T ,-w eighted  M R  im ages 
obtained after addition o f  Gd. T he m ucosa adjacent to the 
sellar floor w as chosen  as the point o f  m easurem ent because  
this region w as the epicenter o f  the m ucosal thickening, 
w hich tapered o ff  in the areas adjacent to the sella  turcica 
w ithin the sphenoid sinus, although som e patients exhibited  
holosphenoidal m ucosal thickening. M u cosal thickness less  
than 1 m m  w as considered normal, w hereas m ucosa thick­
er than 1 m m  w ere considered abnormal, as previously de­
scribed by  Arita, et al.2 A  positive finding w as defined as the 
presence o f  both thickening greater than 1 m m , and en­
hancem ent on T ,-w eighted  G d-enhanced M R  im ages.
A poplexy G radin g  Scale
A  clin ical grading scale for apoplexy (Table 1) w as de­
vised  based on clin ical presentation: Grade I w as assigned  
for the presence o f  acute headaches and/or endocrine abnor­
m alities only; Grade II for the presence o f  the aforem en­
tioned sym ptom s and cranial nerve deficits (visual and/or 
oculom otor); and Grade III for the presence o f  the forego­
ing sym ptom s and a decreased leve l o f  consciousness. The  
patients categorized as Grade I w ere further subclassified  
into Grade la  (absence o f  endocrine abnormality), or Grade 
lb  (presence o f  endocrine abnormalities w ith or w ithout 
headaches).
Results
T he m ost com m on presenting sym ptom  w as an abrupt 
onset o f  headaches, occurring in 27  patients (96% ) (Table
2). O culom otor paresis, defined as a palsy o f  the third, 
fourth, and/or sixth cranial nerve, w as present in nine pa­
tients (32% ). L oss o f  visual fields and/or acuity w as found  
in nine patients (32% ). O nly tw o patients (7% ) present­
ed w ith both oculom otor paresis and visual loss. O ne patient 
(4% ) presented w ith a decreased level o f  consciousness. 
T w elve patients (43% ) had evidence o f  hypopituitarism  
at presentation, three patients (11% ) had m ild diabetes in­
sipidus, and one patient (4% ) had a growth horm one defi­
ciency.
A ccording to the clin ical apoplexy grading scale de­
scribed earlier, 12 patients (43% ) w ere classified  as Grade
I, 15 (53% ) w ere Grade II, and one (4% ) presented as 
Grade III. O f the Grade I patients, 50% w ere subclassified  
in Grade la  and 50% w ere in Grade lb.
P recip ita tin g  F actors
T he majority o f  patients (79% ) had no precipitating fac­
tors im plicated in their apoplectic event. S ix  patients, h ow ­
ever, had a possib le precipitating factor. O f these, one pa­
tient w as receiving growth horm one replacem ent therapy 
and another patient w as being treated w ith bromocriptine 
therapy. O ne patient w as receiving anticoagulation therapy, 
and on e presented im m ediately after an argument. T w o pa­
tients presented w ith pituitary apoplexy im m ediately after 
surgical procedures; one had undergone a total knee re­
placem ent and the other a laparoscopic anterior lumbar in­
terbody fusion.
N euroim aging F indings
In all patients, M R  im ages demonstrated hemorrhage 
and/or infarction in  a pituitary tumor. O nly 11 patients 
(39% ) had undergone CT scanning: nine o f  these had a 
hyperdense lesion  in  the sella  turcica consistent w ith hem ­
orrhage, and tw o had an isodense lesion  consistent w ith  
nonhemorrhagic infarction. T he M R  im aging m odality w as 
sensitive in detecting both a pituitary tumor and hemorrhage 
in 100% o f  cases. T he C T  scans demonstrated a pituitary tu­
mor in 100% o f  cases, but revealed hem orrhage in on ly  82%  
o f  cases.
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TABLE 1
Pituitary apoplexy grading scale*
Grade Description No. of Patients SSMT
I t presence o f acute headaches & /or endo­
crinological abnormalities
12 50%.
II presence o f Grade I symptoms & cranial 
nerve deficits (visual &/or oculomotor)
15 100%
III presence o f Grade I & II symptoms & de­
creased level of consciousness
1 100%
* SSMT = sphenoid sinus mucosal thickening.
t  Grade la  = absence of endocrinological abnormalities; Grade lb = pres­
ence o f endocrinological abnormalities with or without headaches.
Surgical Treatm ent
T w enty-five (89% ) o f  the 28 patients underwent trans­
sphenoidal resection o f  their apoplectic pituitary tumors: 10 
were categorized as Grade I patients, 14 were Grade II, and 
one w as Grade III. The majority o f  these patients (80% ) un­
derwent surgery within 7 2  hours o f  the time o f  diagnosis, 
w hereas five (20% ) o f  the 25 patients underwent surgery 
betw een 5 and 9 days from the tim e o f  diagnosis. H em or­
rhagic and/or necrotic tumors w ere found at surgery in all 
25 patients.
H eadaches resolved in 100% o f  the 25 patients w ho were 
treated surgically. O culom otor paresis also resolved  com ­
pletely in all eight patients w ho had this sym ptom . Visual 
function, including both visual fields and acuity, w as re­
gained com pletely in four (44% ) and partially in five  (56% ) 
o f  nine patients. Preoperative hypopituitarism resolved  in 
three (25% ) o f  12 patients. T w elve patients (43% ) required 
long-term horm one replacem ent therapy (cortisol and thy­
roid replacem ents). M ild  diabetes insipidus in three patients 
at presentation resolved  after surgery; none developed  per­
m anent diabetes insipidus.
N onsu rgica l Treatm ent
In three (11%) o f  the 28 patients, the lesions were m an­
aged nonsurgical ly. One patient presented with acute head­
aches on ly  and had normal pituitary function (Grade la). 
This patient’s case w as m anaged with surveillance M R  im ­
aging. The headaches im proved and the hemorrhage re­
so lved  on follow -up M R  im aging (Fig. 1). The other tw o  
patients had prolactin-secreting adenom as (one Grade la, 
one Grade II) and were treated with dopam ine agonist ther­
apy. Both patients demonstrated normalization o f  serum  
prolactin levels and tumor shrinkage on fo llow -up  M R  im ­
aging. The patient with Grade II apoplexy initially present-
TABLE 2
Clinical presentation o f  pituitary apoplexy in 28 patients
Symptom No. o f Patients (%.)
headaches 27 (96)
ocular paresis 9 (32)
visual field &/or acuity loss 9 (32)
ocular paresis & visual loss 2 (7 )
hypopituitarism 12 (43)
mild diabetes insipidus 3(11)
decreased level o f consciousness 1 (4)
Fig. I. Illustrative ease of Grade la pituitary apoplexy. This 32- 
ycar-old woman presented with a 3-day history of hcadachcs asso­
ciated with nausea. Results of the visual and cranial nerve examina­
tion were normal. Initial sagittal (A) and coronal (B) T rwcightcd 
MR imaging with addition of Gd demonstrated hemorrhage in a 
pituitary tumor, and there was no thickcning of sphenoid sinus mu­
cosa. Tlie tumor was small and did not exhibit compression of the 
optic chiasm or cavcmous sinus on ncuroimagcs. TTic patient was 
treated conservatively with elose observation. Repeated MR im­
aging (sagittal and coronal views; C and D, respectively) at the 
3-month follow-up evaluation demonstrated a dccrcasc in tumor size 
as well as resolution of hemorrhage and nccrosis. This ease illus­
trates successful conservative management of Grade I pituitary apo­
plexy in the absence of endocrinological abnormality and thickened 
sphenoid sinus mucosa.
ed  with headaches and a third cranial nerve palsy, w hich re­
so lved  com pletely within 48  hours o f  initiation o f  dopam ine  
agonist therapy.
Thickening o f  Sphenoid Sinus M ucosa
In 22  patients (79% ), thickening o f  sphenoid sinus m uco­
sa w as observed on M R  im aging at the tim e o f  diagnosis. 
Fifty percent o f  patients in Grade I and 100% o f  those in 
Grades II and III had thickening o f  sphenoid sinus m ucosa. 
Patients with thickened sphenoid sinus m ucosa had a h igh ­
er rate o f  cranial nerve deficits at presentation than those 
w ithout m ucosal thickening (73% com pared with 0%). All 
o f  the Grade I patients w ho exhibited thickening o f  sphe­
noid sinus m ucosa had evidence o f  tumor com pression o f  
either the optic chiasm or cavernous sinus on M R  im aging  
(Fig. 2). Interestingly, none had objective visual or ocu lo­
m otor deficits. The remainder o f  the Grade I patients w ith­
out sphenoid sinus m ucosal thickening did  not experience 
com pression o f  the optic chiasm  or cavernous sinus.
Patients with thickened m ucosa had a higher rate o f  hy­
popituitarism and subsequent long-term horm one replace­
ment therapy than those w ithout this sym ptom  (55%  
com pared with 17%; Fig. 3). O f the 12 patients w ho even-
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Fig. 2. Illustrative case of Grade lb pituitary apoplexy. This 45- 
year-old man awoke with the worst headache of his life. Results of 
his neurological examination were normal with the exception of 
mild diabetes insipidus. Endocrinological workup demonstrated hy- 
pogonadotropic hypogonadism. An unenhanced axial CT scan (A) 
demonstrated a hyperdense lesion in an expanded sella turcica. Ad­
mission MR imaging (B, T-weighted coronal view; C, T-weight- 
ed sagittal view; and D, T,-weighted Gd-enhanced sagittal view) re­
vealed a hemorrhagic macroadenoma with compression on the optic 
chiasm and bilateral cavernous sinuses. The patient did not exhibit 
visual or oculomotor deficits. Thickening and enhancement of the 
sphenoid sinus mucosa of more than I mm was also present (ar­
rows). The patient was started on a regimen of intravenous corti­
costeroid drags and he underwent urgent transsphenoidal resection 
of the pituitary tumor. Postoperatively, his headaches and diabetes 
insipidus resolved, but he required long-term cortisol and thyroid re­
placement therapy.
tually required long-term  horm one replacem ent therapy, 
100% had thickening o f  sphenoid sinus m ucosa (tw o in  
Grade lb , nine in Grade II, and one in  Grade III). O f the 16 
patients w ho did not require long-term  horm one replace­
ment, 62% had thickening o f  sphenoid sinus m ucosa (tw o in 
Grade la , tw o in  Grade lb , and six  in Grade II) and 38% did 
not. A ll five  patients w h o experienced residual visual field  
loss had thickening o f  sphenoid sinus m ucosa.
Discussion
P itu itary  A poplexy in the M R Im aging Era
The use o f  neuroim aging studies to facilitate the diag­
nosis o f  pituitary apoplexy has evo lved  over the last sev ­
eral decades.26 In pituitary apoplexy series published be­
fore 1990, CT w as the dominant neuroim aging study o f  
ch o ice .11-32 In the last 15 years, M R im aging has been used  
increasingly to facilitate tlie diagnosis o f  pituitary apoplexy. 
It is significantly m ore sensitive than C T  scanning in  detect­
ing both a pituitary tumor and an intratumoral hem orrhage
Fig. 3. Illustrative case of Grade II pituitary apoplexy. This 79- 
year-old man presented with acute onset of headaches and bi­
temporal hemianopia. His extraocular movements were intact. En­
docrinological workup revealed hypopituitarism. Admission MR 
imaging (A, T,-weighted sagittal view; B, T,-weighted coronal 
view; C, T,-weighted sagittal view after addition of Gd; and D, T,- 
weighted sagittal view) demonstrated hemorrhage into a pituitary 
macroadenoma with suprasellar extension compressing the optic 
chiasm. Thickening and enhancement of sphenoid sinus mucosa 
was also present (asterisks). The patient was started on intravenous 
corticosteroid drags and he underwent urgent transsphenoidal resec­
tion of the pituitary tumor. Postoperatively, the patient’s headaches 
and visual symptoms improved, but he required long-term cortisol 
and thyroid replacement therapy.
or infarct.417-29 In 1991, M cFadzean, et al.,21 reported on 15 
patients w ith pituitary apoplexy, four (27% ) o f  w hom  un­
derwent M R  im aging. In an analysis in 1993 by B ills, et al.,4 
three (8%) o f  37 patients w ith pituitary apoplexy underwent 
MR im aging. M ore recently, in 2005 , Sem ple, et al.,29 re­
ported on a series o f  62  patients w ith pituitary apoplexy, o f  
w hom  the 37  m ost recently treated patients (60% ) had un­
dergone M R im aging as the primary neuroim aging investi­
gation.
W e describe a contem porary series o f  28 patients in 
w hom  clinical pituitary apoplexy w as diagnosed, supported 
by docum ented M R im aging in 100% o f  patients. In our 
series, 43%  o f  the patients presented w ith headaches or 
endocrine abnormalities alone w ithout cranial neuropathy  
(Grade I apoplexy), thus m aking the specific clin ical d iag­
nosis o f  pituitary apoplexy m ore difficult. H ow ever, MR  
im aging played an important role in facilitating the diag­
nosis by demonstrating a pituitary tumor and an associat­
ed hem orrhage or infarct. Certainly, i f  visual deficits, ocular 
paresis, and a decreased level o f  consciousness w ere present 
along w ith an acute onset o f  headaches, clin ical pituitary 
apoplexy should be suspected im m ediately.
The reported incidence o f  clin ically  sym ptom atic pitu­
itary apoplexy has ranged from  0.6  to 9*%>.e’-7-11 •13-2w-22-24-2e’-29-32 In 
our series, the overall incidence o f  pituitary apoplexy w as
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10%, w hich  is slightly higher than w hat has been reported 
previously. This m ay be due to increased detection o f  Grade
I pituitary apoplexy w ith the increased use o f  M R  im aging. 
It m ay also be attributed to the referral patterns o f  our ter­
tiary care academ ic m edical center. T he increased use o f  C T  
and M R  im aging for the w orkup o f  headaches am ong the 
general population has resulted in  increased detection o f  in­
cidental pituitary adenom as.28 In a recent m etaanalysis by  
Ezzat, et a l.,12 the prevalence o f  pituitary adenom as w as e s­
timated to be 16.7% (14.4%  identified in autopsy studies 
and 22.5%  in neuroim aging studies), w hich  suggests that 
pituitary tumors are extrem ely com m on in the general pop­
ulation. It is p ossib le that the increased use o f  M R  im aging  
in the workup o f  acute headaches m ay be the reason for the 
increased recognition o f  hem orrhagic and necrotic pituitary 
tumors.
Clinical Apoplexy Grading Scale
In our study, the characteristics o f  the patient population, 
including the age and sex  and the distribution o f  clin ical fea­
tures, w ere sim ilar to those in other surgical series o f  pitu­
itary apoplexy.4-26-29 There w as a w id e spectrum o f  present­
ing sym ptom s, ranging from  an acute headache alone to 
visual deficits and ocular paresis, and even  a decreased level 
o f  consciousness. W e describe a grading scale for patients 
w ith pituitary apoplexy based on their initial clin ical pre­
sentation. Our proposed grading scale can be used to classi­
fy  the degree and severity o f  sym ptom s at clin ical presenta­
tion and to help facilitate urgent treatment.
Patients categorized in Grade I (those w ith the presence  
o f  acute headaches and/or endocrine abnormalities only) 
constituted 43%  o f  our patients, w hereas patients in Grade
II (those w ith the presence o f  the aforem entioned sym ptom s 
and visual and/or oculom otor deficits) com prised 53%  o f  
our patients. T hese data support the suggestion  that a sign if­
icant number o f  patients w ith pituitary apoplexy can present 
w ith headaches alone in the absence o f  cranial neuropathies 
or a decreased level o f  consciousness. O ne patient classified  
as Grade I presented w ith increased fatigue from  hypocor- 
tisolem ia w ith no headaches. T he large number o f  patients 
w ith Grade I apoplexy m ay be attributed to detection o f  pi­
tuitary apoplexy in patients w ith less obvious sym ptom s 
or signs, w hich  are detectable on M R  im aging as d iscussed  
earlier.
In m ost series, a decreased level o f  consciousness is an 
uncom m on presenting sym ptom .4-26'29 O nly one patient (4% ) 
in our series w as classified  as Grade III (having the sym p­
tom s o f  Grades I and II as w ell as a decreased level o f  con ­
sciousness), w hich  w as slightly less than in other reported 
series (8-13% ).
Clinical Significance o f  Thickened Sphenoid Sinus Mucosa
The presence o f  thickened sphenoid sinus m ucosa has 
been reported during the acute stage o f  pituitary apoplexy  
(w ithin 7 days after the onset o f  apoplectic sym ptom s).2 In 
our study, 79%  o f  patients had thickening o f  sphenoid sinus 
m ucosa on M R  im aging at the tim e o f  d iagnosis. T his find­
ing w as associated w ith higher grades o f  pituitary apoplexy. 
O f the patients w ith Grades II and III apoplexy, 100% had 
thickening o f  sphenoid sinus m ucosa, w hereas thickening  
w as present in only 50% o f  patients in Grade I. O f the pa­
tients categorized as Grade I, those w ith sphenoid sinus m u­
cosa l thickening had evidence o f  tumor com pression o f  e i­
ther the optic ch iasm  or the cavernous sinus on M R  im ag­
ing. Interestingly, despite the com pression, these patients 
did not exhibit visual or oculom otor deficits on clin ical ex ­
amination. Figure 2  illustrates pathological features in a 
patient w ith  Grade I apoplexy w ho had sphenoid sinus m u­
cosa l thickening and in w h om  radiographically confirm ed  
com pression o f  the optic chiasm  w as found, but w h o  pre­
sented w ith only headaches and no visual or oculom otor d e­
ficits.
T hickening o f  the sphenoid sinus m ucosa during acute 
pituitary apoplexy m ay also be associated w ith a w orse  
endocrinological and neurological outcom e. Patients w ith  
thickened m ucosa had a higher rate o f  hypopituitarism  and 
subsequent long-term  horm one replacem ent therapy than 
those w ithout this characteristic (55  com pared w ith 17%). 
In our study, o f  the 12 patients w ho required long-term  hor­
m one replacem ent therapy, 100% had thickening o f  sphe­
noid sinus m ucosa on the initial M R  im aging studies. O f the 
16 patients w ho did not require long-term  horm one replace­
m ent therapy, 62%  had sphenoid sinus m ucosal thicken­
ing. This suggests that sphenoid sinus m ucosal thickening  
is sensitive but not specific for poor endocrinological out­
com e. This radiological finding should raise concern for 
potential endocrine dysfunction in patients w ith pituitary 
apoplexy. Sim ilarly, each o f  the five  patients w h o experi­
enced persistent visual field  loss or incom plete visual recov­
ery also had thickening o f  sphenoid sinus m ucosa.
Arita, et al.,2 proposed that a p ossib le m echanism  o f  the 
thickening and enhancem ent o f  the sphenoid sinus m ucosa  
m ay be venous congestion  caused by obstruction o f  the out- 
to-in transsellar venous flow , w hich  is attributable to a sud­
den increase in intrasellar pressure. Increased intrasellar 
pressure has a lso been im plicated in the m echanism  o f  h y ­
popituitarism seen  in acute pituitary apoplexy.33 Early sur­
g ica l decom pression can help prevent ischem ic necrosis o f  
the anterior pituitary gland and subsequent hypopituitarism. 
W e believe that thickening o f  the sphenoid sinus m ucosa  
represents an indirect m easure o f  increased intrasellar pres­
sure during the acute stages o f  pituitary apoplexy and 
should raise concern for possib le endocrine dysfunction. 
Our data support the suggestion  that this finding is associat­
ed w ith higher grades o f  apoplexy, larger tumors w ith radio­
graphically confirm ed com pression o f  parasellar structures, 
and w orse endocrinological and neurological outcom es. 
T he true m echanism  for the m ucosal thickening has not 
been defined; in addition to the m echanism  proposed by  
Arita, et al.,2 it is possib le that this condition m ay have an 
endocrinological or neurogenic basis.
Management and Outcome
O nce the d iagnosis o f  pituitary apoplexy is suspected, 
initial m edical m anagem ent requires prompt administration 
o f  corticosteroid m edications and c lo se  m onitoring o f  the 
fluid and electrolyte balance because o f  the high prevalence  
o f  hypopituitarism  and subsequent adrenal insufficiency.1-9'17 
Steroid drugs m ay also im prove visual function. There is 
som e disagreem ent regarding the role o f  early surgery for 
pituitary apoplexy. A lthough cases o f  spontaneous recovery  
w ith conservative treatment have been  reported,14-19-25 m ost 
experienced neurosurgeons have advocated early surgical 
decom pression via the transsphenoidal approach.; 5 * ’
23,26,29,31
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The clin ical course o f  conservatively m anaged pituitary 
apoplexy is often unpredictable, w hereas early transsphe­
noidal surgery effectively  reverses or im proves neurooph- 
thalm ological deficits w ith low  rates o f  morbidity and m or­
tality.4-’6-’9 Patients treated conservatively w ith corticosteroid  
m edications alone m ay have a higher mortality rate.10 Ur­
gent decom pression is advocated in the clin ical setting o f  
visual deterioration or progressive neurological deficits. 
Early decom pression prom otes significant neurological im ­
provement, rapid recovery from  diencephalic sym ptom s, 
resolution o f  ocular paresis, restoration o f  com prom ised v i­
sion, and som etim es, im provem ent o f  pituitary function.U4A
11,18,213033
The tim ing o f  surgery is important for obtaining favor­
able outcom es. In a retrospective analysis o f  37 patients. 
B ills and cow orkers4 found that those w ho underwent 
surgery within 7 days o f  the onset o f  pituitary apoplexy  
achieved significant recovery o f  v isual acuity and resolution  
o f  v isual field  deficits. V isual im provem ent w as retarded in 
patients w ho underwent surgery after the 7th day. Trans­
sphenoidal decom pression resulted in im provem ent in ocu ­
lar paresis in 100%, visual acuity deficits in 88% , and visual 
field  deficits in 95% o f  patients. Randeva, et a l.,’6 also noted  
higher rates o f  com plete resolution o f  ocular paresis in pa­
tients w ho underwent surgery within 8 days (74% ) than in 
those w ho underwent surgery after 8 days (42% ). In a re­
v iew  by Cardoso and Peterson,9 the extent o f  visual re­
covery w as m ore dependent on early transsphenoidal d e­
com pression than on the severity o f  the initial visual loss. 
Patients w ere m ore likely  to recover from  ocular paresis 
than visual loss.
A ll but one o f  the surgically treated patients in our study 
underwent their procedures w ithin 6 days; the rem aining  
one w as treated at 9 days. The majority (80% ) underwent 
transsphenoidal decom pression within 72  hours o f  d iag­
nosis. H eadaches resolved  in 100% o f  patients; oculom otor  
paresis disappeared com pletely in 100%; and visual func­
tion, including both visual fields and acuity, w as regained  
com pletely  in 44%  and partially in 56% . Three (25% ) o f  12 
patients in w hom  hypopituitarism  w as found on presenta­
tion did not require long-term  horm one replacem ent thera­
py after transsphenoidal surgery. Forty-three percent o f  our 
patients required long-term  horm one replacem ent therapy  
N on e suffered permanent diabetes insipidus.
C onservative m anagem ent m ay be considered in care­
fu lly  selected  cases; in our series, pituitary apoplexy w as  
su ccessfu lly  m anaged w ith conservative therapy in three 
patients. The patient w hose case is illustrated in F ig. 1 pre­
sented w ith acute headaches only and had normal pituitary 
function (Grade la  apoplexy). The absence o f  thickening o f  
the sphenoid sinus m ucosa w as associated w ith a low -grade  
hemorrhage. The tumor w as sm all and neuroim aging did 
not reveal com pression o f  parasellar cranial nerves. B e ­
cause the pituitary function w as normal, there w as no endo­
crinological indication for surgery.
Som e patients w ith  prolactin-secreting adenom as m ay  
also be considered for m edical therapy w ith dopam ine ago­
nists i f  severe visual com prom ise is absent. Brism an, et al.,7 
reported on a patient w ith  a m acroprolactinom a w ho pre­
sented w ith pituitary apoplexy and a third cranial nerve pal­
sy, w hich  w as reversed w ith bromocriptine and corticoste­
roid agents. W e treated tw o patients w ith prolactinom as by 
using dopam ine agonist therapy. Both patients demonstrat-
Fig. 4. Illustrative case of Grade II prolactinoma apoplexy. This 
63-year-old man awoke from knee surgery with acute headaches, 
nausea, vomiting, and a right third cranial nerve palsy. His visual 
fields and acuity were intact. An unenhanced axial CT scan (A) 
demonstrated a large isodense lesion arising from the expanded sel­
la turcica, with involvement of the right cavernous sinus. No evi­
dence of hemorrhage was detected. Admission MR imaging (B. Tr 
weighted coronal view after Gd enchancement; and C. T,-weighted 
coronal view) demonstrated a large infarcted pituitary macroadeno­
ma that was compressing the right cavernous sinus. Thickening and 
enhancement of the sphenoid sinus mucosa were present (arrows). 
Tlie patient’s serum prolactin was 5401 ng/ml. for which he re­
ceived intravenous corticosteroid medications and bromocriptine 
therapy. Within 24 to 48 hours, his ophthalmoplegia resolved com­
pletely. Follow-up MR imaging (D. T,-weighted coronal view) per­
formed 3 weeks later revealed dramatic tumor shrinkage. Tlie serum 
prolactin level at the 8-month follow-up evaluation had normalized 
to 6 ng/ml. Panel C is reproduced with permission from Liu JK. 
Couldwell WT: Contemporary management of prolactinomas. Neu­
rosurg Focus 16(4):E2. 2004.
ed  norm alization o f  serum  prolactin and tumor shrinkage on 
fo llow -up  M R  im aging. O ne patient w hose case is illus­
trated in Fig. 4 , presented w ith headaches and a third cranial 
nerve palsy (Grade II) that resolved  com pletely  w ithin 48  
hours o f  initiation o f  dopam ine agonist therapy (this patient 
w as briefly described in a recent review  o f  prolactinom as).16 
W e do not recom m end this treatment i f  severe visual defi­
cits are present. Surgical decom pression should be consid ­
ered i f  cranial nerve palsies do not resolve or i f  the patient 
w orsens neurologically.
Conclusions
The presence o f  thickened sphenoid sinus m ucosa corre­
lates w ith  m ore severe pituitary apoplexy as defined by the
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higher grades o f  the scale proposed in  this paper. T his find­
ing appears to b e associated w ith w orse endocrinological
and visual outcom es.
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